Moody's Investors Service ("Moody's") assigns Baa2 rating to Zimmer Biomet Holdings, Inc. ("ZBH") or ("Zimmer Biomet") proposed $500 million senior unsecured notes. There are no changes to the existing Baa2 senior unsecured ratings. The outlook remains unchanged at stable. Proceeds from the new $...
A director at Zimmer Biomet Holdings Inc bought 2,135 shares at 104.750USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Moody's Investors Service (Moody's) upgraded the senior unsecured ratings of Zimmer Biomet Holdings, Inc. ("ZBH") to Baa2 from Baa3. The outlook is stable. The ratings upgrade reflects the ongoing deleveraging and improved operating performance due to strong demand and operational improvements tha...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.